- $1.37bn
- $2.43bn
- $1.17bn
- 60
- 69
- 78
- 79
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 613 | 773 | 1,039 | 1,121 | 1,175 |
Cost of Revenue | |||||
Gross Profit | 189 | 286 | 425 | 431 | 404 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 628 | 737 | 945 | 1,043 | 1,114 |
Operating Profit | -15 | 36.1 | 94.1 | 78.7 | 60.3 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -63.2 | -25.5 | 40.6 | 29.2 | -23.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -35.1 | -22.2 | 24.2 | 30.4 | -19.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -35.3 | -22.5 | 24 | 30.2 | -19.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -35.3 | -22.5 | 24 | 30.2 | -19.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.364 | -0.199 | 0.327 | 0.339 | -0.063 |
Dividends per Share |